Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Issue of Equity

20 Mar 2015 16:52

RNS Number : 1006I
Maven Income & Growth VCT PLC
20 March 2015
 

Maven Income and Growth VCT PLC

 

Offer for Subscription

 

 

On 20 February 2015, under announcement RNS 5075F, the board of Maven Income and Growth VCT PLC (the Company) confirmed that its offer for subscription (the Offer), which had opened on 20 October 2014, was closed for further applications, with the Company having received valid applications to the value of £4 million pursuant to the Offer, of which applications accepted in respect of the 2014/2015 tax year represented the sum of £3.73 million. As stated in that announcement, 5,506,387 new Ordinary Shares of 10p each in respect of applications for the 2014/2015 tax year were issued and allotted.

 

Further to the above announcement, on 20 March 2015 the Company has issued and allotted a further 203,769 new Ordinary Shares of 10p each in respect of the applications in respect of the 2014/2015 tax year. The offer prices at which these new Ordinary Shares were issued and allotted ranged from £0.64850843 to £0.66858327 per Ordinary Share and, as a result of this further allotment, the Company's issued share capital consists of 54,003,731 Ordinary Shares with voting rights (Voting Capital).

 

The allotment of these additional shares is intended to account for the interim dividend of 2.40p per

Ordinary Share paid on 5 December 2014, which had been included in the Company's net asset value per Ordinary Share (NAV) of 67.25p as at 30 November 2014 that had been used to calculate the allotments made on 20 February 2015. The additional new Ordinary Shares issued by the Company under this allotment will result in each successful applicant having had their full subscription monies in the 2014/15 tax year invested using an adjusted NAV of 64.85p per Ordinary Share and offer prices ranging from £0.64850843 to £0.66858327 per Ordinary Share. In due course an additional share certificate will be issued to each such applicant, along with a revised illustration of the basis of calculation and a replacement tax certificate.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 26 March 2015.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

 

Maven Capital Partners UK LLP

Secretary

 

20 March 2015

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQBLFLEXFZBBK
Date   Source Headline
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202511:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.